Takao Tsuduki
Takao Tsuduki publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Surgery, on topics such as Gastric Cancer Management and Outcomes, Colorectal Cancer Treatments and Studies and Genetic factors in colorectal cancer.
- World rank
- #5,422,333 of 7,710,434 ranked researchers
- Rank in Japan
- #182,235 of 383,136
- Works
- 23
- Citations
- 82
- Citations per work
- 3.6
What does Takao Tsuduki research?
Takao Tsuduki's work is mostly in Medicine (88%), Biochemistry, Genetics and Molecular Biology (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2087.9%
- Medicine2087.9%
- Everything else29.1%
- Life Sciences13.0%
- 1Pulmonary and Respiratory Medicine30% of their works
- 2Oncology30% of their works
- 3Surgery14% of their works
- 4Pathology and Forensic Medicine8% of their works
- 5Gastroenterology6% of their works
- 6Biotechnology3% of their works
Research topics
- Gastric Cancer Management and Outcomes
- Colorectal Cancer Treatments and Studies
- Genetic factors in colorectal cancer
- Gastrointestinal Tumor Research and Treatment
- Cancer Immunotherapy and Biomarkers
- Helicobacter pylori-related gastroenterology studies
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Cancer Research and Treatments
Which keywords describe Takao Tsuduki's research?
The keywords of their largest research topics: Chemotherapy, Molecular Characterization, Gastric Cancer, Endoscopic Resection, Lymph Node Dissection, Cetuximab, KRAS Mutations and Prognostic Factors.
- Bacterial Therapy
- Inflammation
- Helicobacter pylori
- Biliary Tract Cancer
- Imatinib Mesylate
- Hereditary Syndromes
- Prognostic Factors
- Cetuximab
- Endoscopic Resection
- Molecular Characterization
- Chemotherapy
- Gastric Cancer
- Lymph Node Dissection
- KRAS Mutations
- Surgical Management
- Microsatellite Instability
- Sunitinib
- Cholangiocarcinoma
- Immune Checkpoint Blockade
- PD-1 and PD-L1
- Tumor Targeting
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Chemotherapy272 topics
- Molecular Characterization232 topics
- Gastric Cancer212 topics
- Endoscopic Resection181 topic
- Lymph Node Dissection181 topic
- Cetuximab91 topic
- KRAS Mutations91 topic
- Prognostic Factors72 topics
- Surgical Management72 topics
- Hereditary Syndromes51 topic
- Microsatellite Instability51 topic
- Imatinib Mesylate41 topic
- Sunitinib41 topic
- Biliary Tract Cancer31 topic
- Cholangiocarcinoma31 topic
- Helicobacter pylori31 topic
- Immune Checkpoint Blockade31 topic
- Inflammation31 topic
- PD-1 and PD-L131 topic
- Bacterial Therapy21 topic
- Tumor Targeting21 topic
Where does Takao Tsuduki work?
Takao Tsuduki's main affiliation in the publication record is Himeji Red Cross Hospital, Japan.
How many publications and citations does Takao Tsuduki have?
OpenAlex counts 23 works and 82 citations for Takao Tsuduki, an h-index of 6, ranking #5,422,333 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Takao Tsuduki. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.